Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction

ClinicalTrials.gov ID: NCT01364649

Public ClinicalTrials.gov record NCT01364649. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 9:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction

Study identification

NCT ID
NCT01364649
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
447 participants

Conditions and interventions

Interventions

  • Escitalopram Drug
  • Placebo Drug
  • Vortioxetine Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2011
Primary completion
Nov 30, 2013
Completion
Nov 30, 2013
Last update posted
Oct 8, 2014

2011 – 2013

United States locations

U.S. sites
53
U.S. states
25
U.S. cities
53
Facility City State ZIP Site status
Not listed Birmingham Alabama
Not listed Tucson Arizona
Not listed Anaheim California
Not listed Chino California
Not listed Costa Mesa California
Not listed Encino California
Not listed Escondido California
Not listed Irvine California
Not listed Newport Beach California
Not listed Oceanside California
Not listed San Diego California
Not listed Norwich Connecticut
Not listed Washington D.C. District of Columbia
Not listed Coral Springs Florida
Not listed Fort Myers Florida
Not listed Gainesville Florida
Not listed Jacksonville Florida
Not listed Lauderhill Florida
Not listed North Miami Florida
Not listed Orlando Florida
Not listed Sanford Florida
Not listed West Palm Beach Florida
Not listed Atlanta Georgia
Not listed Chicago Illinois
Not listed Joliet Illinois
Not listed Lake Charles Louisiana
Not listed Shreveport Louisiana
Not listed Gaithersburg Maryland
Not listed Towson Maryland
Not listed Boston Massachusetts
Not listed Weymouth Massachusetts
Not listed Flowood Mississippi
Not listed Creve Coeur Missouri
Not listed St Louis Missouri
Not listed Toms River New Jersey
Not listed Willingboro New Jersey
Not listed Albuquerque New Mexico
Not listed New York New York
Not listed Rochester New York
Not listed Staten Island New York
Not listed Cincinnati Ohio
Not listed Dayton Ohio
Not listed Toledo Ohio
Not listed Oklahoma City Oklahoma
Not listed Portland Oregon
Not listed Allentown Pennsylvania
Not listed Philadelphia Pennsylvania
Not listed Memphis Tennessee
Not listed Austin Texas
Not listed Dallas Texas
Not listed Charlottesville Virginia
Not listed Seattle Washington
Not listed Waukesha Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01364649, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 8, 2014 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01364649 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →